Two Sigma Investments’s Cytosorbents Corp CTSO Stock Holding History

Two Sigma Investments’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,666	Closed	-$140K	–	3015
2021 Q4	$140K	Buy	1,666 +702	+73%	+$78.8K	﹤0.01%	3996
2021 Q3	$157K	Sell	964 -2,804	-74%	-$456K	﹤0.01%	4018
2021 Q2	$569K	Sell	3,768 -2,498	-40%	-$421K	﹤0.01%	2982
2021 Q1	$1.09M	Buy	6,266 +2,419	+63%	+$461K	﹤0.01%	2231
2020 Q4	$613K	Sell	3,847 -2,631	-41%	-$440K	﹤0.01%	2355
2020 Q3	$1.03M	Buy	6,478 +2,727	+73%	+$492K	﹤0.01%	1733
2020 Q2	$743K	Buy	+3,751	New	+$689K	﹤0.01%	1730
2020 Q1	–	Sell	-5,435	Closed	-$418K	–	3231
2019 Q4	$418K	Buy	+5,435	New	+$474K	﹤0.01%	2931
2019 Q3	–	Sell	-907	Closed	-$120K	–	3511
2019 Q2	$120K	Sell	907 -1,644	-64%	-$226K	﹤0.01%	3180
2019 Q1	$386K	Buy	2,551 +874	+52%	+$136K	﹤0.01%	2433
2018 Q4	$271K	Buy	1,677 +992	+145%	+$197K	﹤0.01%	2522
2018 Q3	$177K	Sell	685 -8,912	-93%	-$2.23M	﹤0.01%	3030
2018 Q2	$2.19M	Buy	9,597 +4,866	+103%	+$921K	0.01%	1546
2018 Q1	$667K	Buy	+4,731	New	+$715K	﹤0.01%	2283

Other funds holding CTSO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $812M AUM 0.44% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Two Sigma Investments's CTSO Position: Q1 2022 in Review

Two Sigma Investments sold out of Cytosorbents Corp (CTSO) in Q1 2022, closing a stake of 1,666 shares — an estimated $140K sold.

Two Sigma Investments first reported a position in CTSO in Q1 2018 and held it in 14 quarters. The position peaked at $2.19M in Q2 2018. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

Two Sigma Investments reported no remaining Cytosorbents Corp position as of Q1 2022 after selling out during the quarter.
Two Sigma Investments sold 1,666 Cytosorbents Corp shares in Q1 2022, an estimated $140K.
Two Sigma Investments first reported a position in Cytosorbents Corp in Q1 2018 and held it in 14 quarters.
Two Sigma Investments's Cytosorbents Corp position peaked at $2.19M in Q2 2018.
88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.